Recursion Pharmaceuticals Inc. (RXRX) Social Stream



Recursion Pharmaceuticals Inc. (RXRX): $9.91

0.31 (+3.23%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Recursion Pharmaceuticals Inc (RXRX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RXRX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-11 5 $37 $30 $33.5 $6.91 384.8%
2021-12-07 5 $37 $30 $33 $6.91 377.57%
2021-12-08 5 $37 $31 $34.2 $6.91 394.93%
2022-01-14 5 $37 $28 $32.8 $6.91 374.67%
2022-03-04 4 $37 $10 $26.5 $6.91 283.5%

The Trend in the Analyst Price Target


RXRX's average price target has moved down $4 over the prior 26 weeks.

RXRX reports an average of 72.24% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 NA 36 31 33.5 31.23 7.27%
2021-08-05 NA 36 31 33.5 31.38 6.76%
2021-09-04 NA 36 30 32.4 27.01 19.96%
2021-11-10 5 37 30 33.0 16.14 104.46%
2022-01-14 5 37 28 32.8 13.81 137.51%

RXRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 2 0 2 0 0 4

The Trend in the Broker Recommendations


RXRX's average broker recommendation rating worsened by 0.6 over the prior 120 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Recursion Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 564.2% of them.
  • To contextualize these metrics, consider that out of all US stocks, Recursion Pharmaceuticals Inc's variance in analysts' estimates is lower than -185.73% of them.
  • In terms of how Recursion Pharmaceuticals Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 143.94% of that group.
  • In terms of how Recursion Pharmaceuticals Inc fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 219.03% of that group.

In the Pharmaceutical Products industry, RVMD, RUBY, and RLAY are the three stocks most similar to Recursion Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding RXRX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3551 seconds.